US Patent 8795669 Stabilized formulations containing anti-PCSK9 antibodies

Patent 8795669 was granted and assigned to Regeneron Pharmaceuticals, Inc. on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87956690

Patent Inventor Names

Daniel Dix0

Scott Walsh0

Date of Patent

August 5, 2014

Patent Application Number

135598620

Date Filed

July 27, 2012

Patent Citations Received

‌

US Patent 12066246 Target residual moisture content for lyophilized drug product

‌

US Patent 11673967 Stabilized formulations containing anti-PCSK9 antibodies

‌

US Patent 11713922 Target residual moisture content for lyophilized drug product

‌

US Patent 11904017 Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab

Patent Primary Examiner

‌

Vanessa L. Ford

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8795669 Stabilized formulations containing anti-PCSK9 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API